Adenosine 5'-methylenediphosphate
Star0
Identification
- Generic Name
- Adenosine 5'-methylenediphosphate
- DrugBank Accession Number
- DB03148
- Background
Not Available
- Type
- Small Molecule
- Groups
- Experimental
- Structure
- Weight
- Average: 425.2283
Monoisotopic: 425.050150191 - Chemical Formula
- C11H17N5O9P2
- Synonyms
- Adenosine 5'-(hydrogen (phosphonomethyl)phosphonate)
- Adenosine, 5'-(trihydrogen methylenebis(phosphonate))
- Phosphomethylphosphonic acid adenosyl ester
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
- Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API
- Pharmacodynamics
Not Available
- Mechanism of action
Target Actions Organism UDNA Not Available Humans URibose-phosphate pyrophosphokinase Not Available Bacillus subtilis (strain 168) UMutT/nudix family protein Not Available Mycobacterium tuberculosis UProtein UshA Not Available Escherichia coli (strain K12) - Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
- Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.
- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs Browse all" title="About SNP Mediated Effects/ADRs" id="snp-actions-info" class="drug-info-popup" href="javascript:void(0);">
- Not Available
Interactions
- Drug Interactions Learn More" title="About Drug Interactions" id="structured-interactions-info" class="drug-info-popup" href="javascript:void(0);">
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Categories
- Drug Categories
- Chemical TaxonomyProvided by Classyfire
- Description
- This compound belongs to the class of organic compounds known as purine ribonucleoside monophosphates. These are nucleotides consisting of a purine base linked to a ribose to which one monophosphate group is attached.
- Kingdom
- Organic compounds
- Super Class
- Nucleosides, nucleotides, and analogues
- Class
- Purine nucleotides
- Sub Class
- Purine ribonucleotides
- Direct Parent
- Purine ribonucleoside monophosphates
- Alternative Parents
- Glycosylamines / 6-aminopurines / Pentoses / Bisphosphonates / Aminopyrimidines and derivatives / Phosphonic acid esters / Imidolactams / N-substituted imidazoles / Organic phosphonic acids / Heteroaromatic compounds show 10 more
- Substituents
- 1,2-diol / 6-aminopurine / Alcohol / Amine / Aminopyrimidine / Aromatic heteropolycyclic compound / Azacycle / Azole / Bisphosphonate / Glycosyl compound show 27 more
- Molecular Framework
- Aromatic heteropolycyclic compounds
- External Descriptors
- nucleoside diphosphate analogue (CHEBI:40730)
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- 0T2A5439OE
- CAS number
- 3768-14-7
- InChI Key
- OLCWZBFDIYXLAA-IOSLPCCCSA-N
- InChI
- InChI=1S/C11H17N5O9P2/c12-9-6-10(14-2-13-9)16(3-15-6)11-8(18)7(17)5(25-11)1-24-27(22,23)4-26(19,20)21/h2-3,5,7-8,11,17-18H,1,4H2,(H,22,23)(H2,12,13,14)(H2,19,20,21)/t5-,7-,8-,11-/m1/s1
- IUPAC Name
- [({[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl)methyl]phosphonic acid
- SMILES
- NC1=NC=NC2=C1N=CN2[C@@H]1O[C@H](COP(O)(=O)CP(O)(O)=O)[C@@H](O)[C@H]1O
References
- General References
- Not Available
- External Links
- PubChem Compound
- 92199
- PubChem Substance
- 46508257
- ChemSpider
- 83239
- BindingDB
- 18136
- ChEBI
- 40730
- ChEMBL
- CHEMBL583969
- ZINC
- ZINC000013527614
- PDBe Ligand
- AP2
- PDB Entries
- 1av5 / 1dku / 1hpu / 1mr2 / 2vqd / 3dgr / 3fd5 / 3vth / 3zu0 / 4h2i … show 11 more
Clinical Trials
- Clinical Trials Learn More" title="About Clinical Trials" id="clinical-trials-info" class="drug-info-popup" href="javascript:void(0);">
Phase Status Purpose Conditions Count
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
- Not Available
- Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Solid
- Experimental Properties
- Not Available
- Predicted Properties
Property Value Source Water Solubility 3.36 mg/mL ALOGPS logP -1.9 ALOGPS logP -6 Chemaxon logS -2.1 ALOGPS pKa (Strongest Acidic) 0.89 Chemaxon pKa (Strongest Basic) 4.92 Chemaxon Physiological Charge -2 Chemaxon Hydrogen Acceptor Count 12 Chemaxon Hydrogen Donor Count 6 Chemaxon Polar Surface Area 223.37 Å2 Chemaxon Rotatable Bond Count 6 Chemaxon Refractivity 87.3 m3·mol-1 Chemaxon Polarizability 35.56 Å3 Chemaxon Number of Rings 3 Chemaxon Bioavailability 0 Chemaxon Rule of Five No Chemaxon Ghose Filter No Chemaxon Veber's Rule No Chemaxon MDDR-like Rule Yes Chemaxon - Predicted ADMET Features
Property Value Probability Human Intestinal Absorption - 0.8991 Blood Brain Barrier + 0.8723 Caco-2 permeable - 0.725 P-glycoprotein substrate Non-substrate 0.5208 P-glycoprotein inhibitor I Non-inhibitor 0.8699 P-glycoprotein inhibitor II Non-inhibitor 0.9788 Renal organic cation transporter Non-inhibitor 0.9623 CYP450 2C9 substrate Non-substrate 0.8741 CYP450 2D6 substrate Non-substrate 0.8309 CYP450 3A4 substrate Non-substrate 0.5558 CYP450 1A2 substrate Non-inhibitor 0.8474 CYP450 2C9 inhibitor Non-inhibitor 0.9129 CYP450 2D6 inhibitor Non-inhibitor 0.8768 CYP450 2C19 inhibitor Non-inhibitor 0.8962 CYP450 3A4 inhibitor Non-inhibitor 0.8252 CYP450 inhibitory promiscuity Low CYP Inhibitory Promiscuity 0.9691 Ames test Non AMES toxic 0.7767 Carcinogenicity Non-carcinogens 0.8649 Biodegradation Not ready biodegradable 0.972 Rat acute toxicity 2.5669 LD50, mol/kg Not applicable hERG inhibition (predictor I) Weak inhibitor 0.9551 hERG inhibition (predictor II) Non-inhibitor 0.7477
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
Spectrum Spectrum Type Splash Key Predicted MS/MS Spectrum - 10V, Positive (Annotated) Predicted LC-MS/MS splash10-004i-0001900000-08bdbc14992bec2884e4 Predicted MS/MS Spectrum - 10V, Negative (Annotated) Predicted LC-MS/MS splash10-00di-0000900000-e86eaea6c40fd20ef3b2 Predicted MS/MS Spectrum - 20V, Positive (Annotated) Predicted LC-MS/MS splash10-0fc9-0539300000-08772382fcb16eb82600 Predicted MS/MS Spectrum - 20V, Negative (Annotated) Predicted LC-MS/MS splash10-05di-8401900000-da1b47649d6b97597023 Predicted MS/MS Spectrum - 40V, Positive (Annotated) Predicted LC-MS/MS splash10-000i-0910000000-92fbfe3bb9dbaef5084d Predicted MS/MS Spectrum - 40V, Negative (Annotated) Predicted LC-MS/MS splash10-003r-7903000000-4dd1a057fcdb48f07497 Predicted 1H NMR Spectrum 1D NMR Not Applicable Predicted 13C NMR Spectrum 1D NMR Not Applicable - Chromatographic Properties
Collision Cross Sections (CCS)
Adduct CCS Value (Å2) Source type Source [M-H]- 170.9234 predictedDeepCCS 1.0 (2019) [M+H]+ 173.31897 predictedDeepCCS 1.0 (2019) [M+Na]+ 179.23149 predictedDeepCCS 1.0 (2019)
Targets
Build, predict & validate machine-learning models
Use our structured and evidence-based datasets to unlock newinsights and accelerate drug research.
Use our structured and evidence-based datasets to unlock new insights and accelerate drug research.
1. DetailsDNA
Unknown
References
2. DetailsRibose-phosphate pyrophosphokinase
- Kind
- Protein
- Organism
- Bacillus subtilis (strain 168)
- Pharmacological action
- Unknown
- General Function
- Ribose phosphate diphosphokinase activity
- Specific Function
- Involved in the biosynthesis of ribose 1,5-bisphosphate. Catalyzes the transfer of pyrophosphoryl group from ATP to ribose-5-phosphate to yield phosphoribosyl diphosphate (PRPP) and AMP.
- Gene Name
- prs
- Uniprot ID
- P14193
- Uniprot Name
- Ribose-phosphate pyrophosphokinase
- Molecular Weight
- 34867.88 Da
References
3. DetailsMutT/nudix family protein
- Kind
- Protein
- Organism
- Mycobacterium tuberculosis
- Pharmacological action
- Unknown
- General Function
- Manganese ion binding
- Specific Function
- Not Available
- Gene Name
- Not Available
- Uniprot ID
- O33199
- Uniprot Name
- MutT/nudix family protein
- Molecular Weight
- 22892.68 Da
4. DetailsProtein UshA
- Kind
- Protein
- Organism
- Escherichia coli (strain K12)
- Pharmacological action
- Unknown
- General Function
- Udp-sugar diphosphatase activity
- Specific Function
- Degradation of external UDP-glucose to uridine monophosphate and glucose-1-phosphate, which can then be used by the cell.
- Gene Name
- ushA
- Uniprot ID
- P07024
- Uniprot Name
- Protein UshA
- Molecular Weight
- 60823.625 Da
Drug created at June 13, 2005 13:24 / Updated at June 12, 2020 16:52